TapImmune Inc. (TPIM) Announces Another Confirmation on Tap As Cancer Therapy, Article by Beacon Equity
BeaconEquity.com announces the publication of the article highlighting TapImmune Inc. and its advances toward vaccines for infectious diseases using its proprietary TAP technology, featured in Journal of Investigative Dermatology.
View full press release